4//SEC Filing
Ajer Jeffrey Robert 4
Accession 0001209191-23-050220
CIK 0000906709other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 8:06 PM ET
Size
7.5 KB
Accession
0001209191-23-050220
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
Director
Transactions
- Sale
Common Stock
2023-09-18$0.69/sh−4,359$3,008→ 34,153 total - Award
Stock Option
2023-09-19+85,000→ 85,000 totalExercise: $0.68Exp: 2031-09-18→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction.
- [F2]This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001557533
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 8:06 PM ET
- Size
- 7.5 KB